Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropharmacology

• Publication date

  2017-07-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2017.04.025PMID 28431972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria.

  2017cited by this paper
• The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence

  2017cited by this paper
• Psychiatric disorders biochemical pathways unraveled by human brain proteomics

  2017cited by this paper
• Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression

  2017cited by this paper
• Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder

  2017cited by this paper
• The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression

  2016cited by this paper
• Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria.

  2016cited by this paper
• Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders

  2016cited by this paper
• Mitochondrial Dysfunction in Depression

  2016cited by this paper
• REGION-SPECIFIC REGULATION OF THE SEROTONIN 2 A RECEPTOR EXPRESSION IN DEVELOPMENT AND AGING IN POSTMORTEM HUMAN BRAIN

  2016cited by this paper
• Brain glucose metabolism in an animal model of depression.

  2015cited by this paper
• Region‐specific regulation of the serotonin 2A receptor expression in development and ageing in post mortem human brain

  2015cited by this paper
• Pharmacological therapy of acute ischaemic stroke: Achievements and problems.

  2015cited by this paper
• Central Presynaptic Terminals Are Enriched in ATP but the Majority Lack Mitochondria

  2015cited by this paper
• Mitochondrial bioenergetics and neuronal survival modelled in primary neuronal culture and isolated nerve terminals

  2015cited by this paper
• Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression

  2015cited by this paper
• Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males

  2015cited by this paper
• Neuroprotection for ischaemic stroke: current status and challenges.

  2015cited by this paper
• Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology.

  2015cited by this paper
• Fluvoxamine alters the activity of energy metabolism enzymes in the brain.

  2014cited by this paper
• Quantitative Proteomics of Synaptic and Nonsynaptic Mitochondria: Insights for Synaptic Mitochondrial Vulnerability

  2014cited by this paper
• Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes.

  2013cited by this paper
• Mitochondrial Functions in Mood Disorders

  2013cited by this paper
• Functional proteomics related to energy metabolism of synaptosomes from different neuronal systems of rat hippocampus during aging.

  2013cited by this paper
• Mitochondrial plasticity of the hippocampus in a genetic rat model of depression after antidepressant treatment

  2013cited by this paper
• Monoamine neurocircuitry in depression and strategies for new treatments.

  2013cited by this paper
• Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing.

  2012cited by this paper
• Effect of CDP-choline on age-dependent modifications of energy- and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex.

  2012cited by this paper
• Bigenomic regulation of cytochrome c oxidase in neurons and the tight coupling between neuronal activity and energy metabolism.

  2012cited by this paper
• Neural circuits underlying the pathophysiology of mood disorders.

  2012cited by this paper
• Pharmacotherapy and prevention of vascular dementia.

  2011cited by this paper
• The Effects of Antidepressants on Mitochondrial Function in a Model Cell System and Isolated Mitochondria

  2011cited by this paper
• Assessing mitochondrial dysfunction in cells

  2011cited by this paper
• Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain.

  2011influential reference
• Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants

  2011cited by this paper
• Cerebral oxygenation and metabolism during exercise following three months of endurance training in healthy overweight males.

  2009cited by this paper
• he effect of chronic fluoxetine on social isolation-induced changes on ucrose consumption , immobility behavior , and on serotonin and opamine function in hippocampus and ventral striatum

  2009cited by this paper
• Nortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia Injury

  2008cited by this paper
• Cerebral oxygenation.

  2008influential reference
• Spectrophotometric assay of cytochrome c oxidase.

  2006influential reference
• Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats.

  2006cited by this paper
• Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

  2005cited by this paper
• The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.

  2004cited by this paper
• Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

  2004cited by this paper
• Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.

  2003cited by this paper
• Affective disorders, antidepressant drugs and brain metabolism

  2003cited by this paper
• Structural Damage Induced by Peroxidation May Account for Functional Impairment of Heavy Synaptic Mitochondria

  2002cited by this paper
• Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression.

  2001cited by this paper
• Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment.

  2000cited by this paper
• Neuroimaging studies of mood disorders.

  2000cited by this paper
• Neuroimaging in bipolar disorder: what have we learned?

  2000cited by this paper
• Second Messenger‐Regulated Protein Kinases in the Brain

  2000cited by this paper
• Prefrontal Cortical‐Amygdalar Metabolism in Major Depression

  1999cited by this paper
• Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

  1999cited by this paper
• Neurobiology of lithium: an update.

  1998cited by this paper
• Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord.

  1997cited by this paper
• Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non‐synaptic mitochondria of aged rats

  1997cited by this paper
• Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord.

  1997cited by this paper
• Pharmacology of Lazaroids and Brain Energy Metabolism: A Review

  1997cited by this paper
• A molecular and cellular theory of depression.

  1997cited by this paper
• Pharmacology of lazaroids and brain energy metabolism: a review.

  1997cited by this paper
• Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria fromMacaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine

  1996cited by this paper
• Modulation of Protein Kinase C Isozymes and Substrates by Lithium: The Role of Myo-inositol

  1996cited by this paper
• Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

  1995cited by this paper
• Effect of long-term in vivo treatment with imipramine on the oxidative energy metabolism in rat brain mitochondria.

  1995cited by this paper
• Factors affecting the rate and energetics of mitochondrial oxidative phosphorylation.

  1994cited by this paper
• Distribution of α2-adrenergic receptor subtype gene expression in rat brain

  1994cited by this paper
• 212 In vivo measurement of extracellular serotonin (5-ht) concentration in the rat brain during prolonged exercise

  1994cited by this paper
• Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain.

  1994cited by this paper
• Effect of fluoxetine on rat liver mitochondria.

  1994cited by this paper
• New Biochemical Hypotheses on the Mechanism of Action of Antidepressant Drugs: cAMP - Dependent Phosphorylation System

  1992cited by this paper
• Mitochondrial factors involved in Parkinson's disease by MPTP toxicity inMacaca fascicularis and drug effect

  1992cited by this paper
• A critique on the preparation and enzymatic characterization of synaptic and nonsynaptic mitochondria from hippocampus

  1989cited by this paper
• Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice.

  1989cited by this paper
• Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate.

  1988cited by this paper
• Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria.

  1986cited by this paper
• Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine

  1985cited by this paper
• Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: interactions with reserpine.

  1983cited by this paper
• The action of chlorpromazine and imipramine on rat brain mitochondria.

  1979cited by this paper
• Mammalian succinate dehydrogenase.

  1978influential reference
• [47] Mammalian succinate dehydrogenase

  1978influential reference
• SYNAPTIC AND NON‐SYNAPTIC MITOCHONDRIA FROM RAT BRAIN: ISOLATION AND CHARACTERIZATION

  1977cited by this paper
• Activities of citrate synthase, NAD+-linked and NADP+-linked isocitrate dehydrogenases, glutamate dehydrogenase, aspartate aminotransferase and alanine aminotransferase in nervous tissues from vertebrates and invertebrates.

  1975influential reference
• Oxidation and reduction of soluble cytochrome c by membrane-bound oxidase and reductase systems.

  1974influential reference
• [45] Cytochrome oxidase from beef heart mitochondria

  1967influential reference
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966cited by this paper
• [57] Lipid-dependent DPNH-cytochrome c reductase from mammalian skeletal and heart muscle: DPNH + 2 ferricytochrome c → DPN+ + 2-ferrocytochrome c + H+

  1963influential reference
• [123] Malic dehydrogenase from pig heart: l-Malate + DPN + ⇆ Oxalacetate + DPNH + H+

  1955influential reference
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• SIGNAL TRANSDUCTION PATHWAYS

  year unknowncited by this paper

• Cerebral metabolic rate of oxygen is correlated to treatment effect of electroconvulsive therapy in patients with depression.

  2025cites this paper
• Prefrontal Cortex Molecular Signatures of Chronically Socially Isolated Rats and Their Response to Fluoxetine Treatment

  2025cites this paper
• Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders

  2025cites this paper
• Effects of Chronic Hypertension on the Energy Metabolism of Cerebral Cortex Mitochondria in Normotensive and in Spontaneously Hypertensive Rats During Aging

  2024cites this paper
• Evaluating the efficacy and mechanisms of a ketogenic diet as adjunctive treatment for people with treatment-resistant depression: A protocol for a randomised controlled trial.

  2024cites this paper
• Reduced expression of the serotonin transporter impacts mitochondria in a sexually dimorphic manner

  2024cites this paper
• Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model

  2023cites this paper
• Connecting Dots between Mitochondrial Dysfunction and Depression

  2023cites this paper
• Brain Bioenergetics in Chronic Hypertension: Risk Factor for Acute Ischemic Stroke.

  2022cites this paper
• Baicalin improves the energy levels in the prefrontal cortex of mice exposed to chronic unpredictable mild stress

  2022cites this paper
• Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

  2022cites this paper
• Alterations of mitochondrial dynamics in serotonin transporter knockout rats: A possible role in the fear extinction recall mechanisms

  2022cites this paper
• Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling

  2022cites this paper
• Centella asiatica (L.) Urb. Extract ameliorates branched-chain amino acid (BCAA) metabolism in acute reserpine-induced stress zebrafish model via 1H Nuclear Magnetic Resonance (NMR)-based metabolomics approach.

  2022cites this paper
• Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects

  2022cites this paper
• Mitochondrial-Targeting Therapeutic Strategies In The Treatment Of Depression.

  2021cites this paper
• Study of Tissue-Specific Reactive Oxygen Species Formation by Cell Membrane Microarrays for the Characterization of Bioactive Compounds

  2021cites this paper
• Effects of Baicalin on the ATP Levels in the Prefrontal Cortex in Mice Exposed to Chronic Unpredictable Mild Stress

  2021cites this paper
• Mitochondrial dysfunction and affective disorders: Focus on diet, exercise, and aging

  2021cites this paper
• Synaptic ATPases and energy metabolism in the nervous system

  2021cites this paper
• The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

  2021cites this paper
• Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis

  2021cites this paper
• Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression

  2021cites this paper
• The social nature of mitochondria_ Implications for human health

  2021cites this paper
• Effect of neuropsychiatric medications on mitochondrial function; for better or for worse.

  2021cites this paper
• Mitochondria under the spotlight: On the implications of mitochondrial dysfunction and its connectivity to neuropsychiatric disorders

  2020cites this paper
• Mitochondrial function and stress resilience

  2020cites this paper
• The treament of hyperglycemia in acute ischemic stroke with incretin-based drugs.

  2020cites this paper
• Effects of resveratrol on the levels of ATP, 5-HT and GAP-43 in the hippocampus of mice exposed to chronic unpredictable mild stress.

  2020cites this paper
• Chronic fluoxetine or ketamine treatment differentially affects brain energy homeostasis which is not exacerbated in mice with trait suboptimal mitochondrial function

  2020cites this paper
• Molecular correlates of mitochondrial dysfunctions in major depression: evidence from clinical and rodent studies.

  2020cites this paper
• The olfactory deficits of depressed patients are restored after remission with venlafaxine treatment

  2020cites this paper
• Synaptic ATPases system of rat frontal cerebral cortex during aging.

  2019cites this paper
• Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.

  2019cites this paper
• Psychiatric drugs impact mitochondrial function in brain and other tissues.

  2019cites this paper
• The Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment

  2019cites this paper
• Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages

  2019cites this paper
• Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models.

  2019cites this paper
• A comprehensive metabolomics investigation of hippocampus, serum, and feces affected by chronic fluoxetine treatment using the chronic unpredictable mild stress mouse model of depression

  2019cites this paper
• Does obesity and diabetes mellitus metastasize to the brain? “Metaboptosis” and implications for drug discovery and development

  2019cites this paper
• Modulation of neuroplasticity‐related targets following stress‐induced acute escape deficit

  2019cites this paper
• Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

  2019cites this paper
• The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1.

  2019cites this paper
• Mitochondrial proteomics investigation of frontal cortex in an animal model of depression: Focus on chronic antidepressant drugs treatment

  2018cites this paper
• Reduction in the Level of Plasma Mitochondrial DNA in Human Diving, Followed by an Increase in the Event of an Accident

  2018cites this paper
• Glutamate metabolism in cerebral mitochondria after ischemia and post‐ischemic recovery during aging: relationships with brain energy metabolism

  2018cites this paper
• Proteomic characterization of hippocampus of chronically socially isolated rats treated with fluoxetine: Depression‐like behaviour and fluoxetine mechanism of action

  2018cites this paper
• Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

  2018cites this paper
• Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression

  2018cites this paper
• Psychophysical stress disturbs expression of mitochondrial biogenesis markers in hypothalamus and adenohypophysis

  2017influential citation
• Post‐stroke depression: Mechanisms and pharmacological treatment

  2017cites this paper